Discovery and functional characterization of small molecule inhibitors of SWI/SNFATPase activity in BRG1/SMARCA4-Deficient non small cell lung cancers

被引：0
|
作者：
Jagani, Z. [1 ]
Chenail, G. [1 ]
Xiang, K. [1 ]
Bushold, G. [1 ]
Bhang, C. [1 ]
Li, A. [1 ]
Vattay, A. [1 ]
Gilbert, T. [1 ]
Zhu, J. [2 ]
Terranova, R. [3 ]
Dubost, V. [3 ]
Huet, F. [4 ]
Farley, D. [5 ]
Cantwell, J. [6 ]
Ruddy, D. [1 ]
Rakiec, D. [1 ]
Shirley, M. [1 ]
Elliott, G. [1 ]
Nakajima, K. [7 ]
Papillon, J. [7 ]
机构：
[1] Novartis Inst BioMed Res, Oncol, Cambridge, MA USA
[2] Novartis Inst BioMed Res, Sci Data Analyt, Cambridge, MA USA
[3] Novartis Inst BioMed Res, Preclin Safety, Basel, Switzerland
[4] Novartis Inst BioMed Res, PreClin Safety, Cambridge, MA USA
[5] Novartis Inst BioMed Res, Chem Biol & Therapeut, Cambridge, MA USA
[6] Novartis Inst BioMed Res, Prot Sci, Emeryville, CA USA
[7] Novartis Inst BioMed Res, Global Discovery Chem, Cambridge, MA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19 (PB-199
引用
收藏
页码：E23 / E23
页数：1
相关论文
共 50 条
  • [31] MAX Inactivation in Small Cell Lung Cancer Disrupts MYC-SWI/SNF Programs and Is Synthetic Lethal with BRG1
    Romero, Octavio A.
    Torres-Diz, Manuel
    Pros, Eva
    Savola, Suvi
    Gomez, Antonio
    Moran, Sebastian
    Saez, Carmen
    Iwakawa, Reika
    Villanueva, Alberto
    Montuenga, Luis M.
    Kohno, Takashi
    Yokota, Jun
    Sanchez-Cespedes, Montse
    CANCER DISCOVERY, 2014, 4 (03) : 292 - 303
  • [32] MAX inactivation in small cell lung cancer disrupts the MYC-SWI/SNF programs and is synthetic lethal with BRG1
    Torres-Diz, Manuel
    Romero, Octavio A.
    Pros, Eva
    Savola, Suvi
    Gomez, Antonio
    Moran, Sebastian
    Montuenga, Luis M.
    Yokota, Jun
    Sanchez-Cespedes, Montse
    MOLECULAR CANCER RESEARCH, 2015, 13
  • [33] Loss of BRG1 and BRM protein expression in a subset of non-small cell lung carcinoma
    Funkhouser, WK
    Reisman, D
    FASEB JOURNAL, 2003, 17 (04): : A252 - A252
  • [34] Effective treatment strategies and key factors influencing therapeutic efficacy in advanced SMARCA4-deficient non-small cell lung cancer
    Liu, Hui
    Hong, Qiyuan
    Zheng, Shuohan
    Zhang, Meifang
    Cai, Ling
    LUNG CANCER, 2024, 198
  • [35] 18F-FDG PET/CT in a case of SMARCA4-deficient poorly differentiated non-small cell lung cancer
    Ma, Y.
    Li, Y.
    Li, X.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S847 - S847
  • [36] Max inactivation in small cell lung cancer disrupts the MYC-SWI/SNF programs and is synthetic lethal with BRG1
    Romero-Ferraro, Octavio A.
    Torres-Diz, Manuel
    Pros, Eva
    Gomez Moruno, Antonio
    Moran Salama, Sebastian
    Savola, Suvi
    Montuenga, Luis M.
    Pio, Ruben
    Yokota, Jun
    Sanchez-Cespedes, Montse
    CANCER RESEARCH, 2014, 74 (19)
  • [37] Successful treatment with nivolumab for SMARCA4-deficient non-small cell lung carcinoma with a high tumor mutation burden: A case report
    Naito, Tomoyuki
    Umemura, Shigeki
    Nakamura, Hiroshi
    Zenke, Yoshitaka
    Udagawa, Hibiki
    Kirita, Keisuke
    Matsumoto, Shingo
    Yoh, Kiyotaka
    Niho, Seiji
    Motoi, Noriko
    Aokage, Keijyu
    Tsuboi, Masahiro
    Ishii, Genichiro
    Goto, Koichi
    THORACIC CANCER, 2019, 10 (05) : 1285 - 1288
  • [38] Additional Considerations on Aberrant BRG1 (SMARCA4) Expression in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT)
    Cyrta, Joanna
    Brillet, Riwan
    Laas, Enora
    Just, Pierre-Alexandre
    Andrianteranagna, Mamy
    Leary, Alexandra
    Vincent-Salomon, Anne
    Bourdeaut, Franck
    Masliah-Planchon, Julien
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2024, 48 (10) : 1335 - 1338
  • [39] Targeting MET: Discovery of Small Molecule Inhibitors as Non-Small Cell Lung Cancer Therapy
    Wang, Chaofan
    Lu, Xiaoyun
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (12) : 7670 - 7697
  • [40] Novel functional insights revealed by distinct protein-protein interactions of the residual SWI/SNF complex in SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type
    Raupach, Elizabeth
    Garcia-Mansfield, Krystine
    Sharma, Ritin
    Hegde, Apurva
    David-Dirgo, Victoria
    Wang, Yemin
    Shin, Chae Young
    Tao, Lan
    Facista, Salvatore
    Moore, Rayvon
    Lang, Jessica
    Zismann, Victoria
    Orlando, Krystal
    Spillman, Monique
    Karnezis, Anthony
    Bennett, Lynda
    Huntsman, David
    Trent, Jeffrey
    Hendricks, William
    Weissman, Bernard
    Pirrotte, Patrick
    CANCER RESEARCH, 2020, 80 (16)
12345